Interim Results

Swallowfield PLC 24 February 2005 Swallowfield plc Interim results for the 28 weeks ended 8 January 2005 Chairman's Statement Results I am pleased to report, that for the first six months of the financial year, turnover increased by 5% from £23.4m to £24.7m and profit before tax increased by 68% to £0.6m. This is a good result when measured against the set of unfavourable background conditions to which we are subject, and that I described in my last report. The personal care market has remained weak and customer imposed price pressure has continued. In addition, we have witnessed a limited resurgence of raw material price inflation driven by higher costs of petrochemical derivatives and base metals such as aluminium and tinplate. Our strategy to address these factors has been effective to date. Savings from last year's restructuring programme are broadly on track, and we have been able to re-invest approximately half of these savings to begin to build our operation in the Peoples' Republic of China. This new operation is growing steadily - we have had our first finished product manufactured by local sub-contractors and have placed purchase orders for newly tooled components. Turnover in the Cosmetics business increased by 6% from £6.3m to £6.7m and, encouragingly, this division made an operating profit of £0.1m following an operating loss of £0.3m over the same period last year. This turnaround has been achieved through a combination of improved sales performance from recently launched product ranges and overhead savings made during the last two years. Turnover in the Aerosols division increased 5% from £17.2m to £18.0m, and operating profit decreased by 10% to £0.8m - the increased pricing pressure on toiletry gift packs has been particularly noticeable during the last 6 months. We are taking positive steps to value engineer new products and increase the sourcing of components from the Far East. Cash and Net Debt The Group has generated operating cash flow of £5.1m since the last year-end as a result of which net debt has been reduced by £3.6m to £5.2m. Much of this improvement comes from the completion of a single customer contract with extended payment terms described in my last report, together with other seasonal factors. Gearing stands at 42% compared with 73% at the end of the last financial year and 44% at the interim stage last year. During the last six months we have prudently increased our expenditure on fixed assets totalling £0.9m, with particular emphasis being placed on good manufacturing practice. We have recently completed the installation of a new microbiological testing facility and a new water treatment plant. Strategy Update We continue to refine our strategy in the light of new information and changes within our market place. We are also exploring potential acquisitions that could either provide extensions to our product capabilities and/or create synergistic benefits with our current operations. At the same time, we are examining opportunities to organically grow our business. Following efforts made over the last several months, we have very recently been awarded a significant outsourcing contract by a well-known brand. Under this contract, Swallowfield will manufacture the majority of this customer's aerosol requirement for an initial term of three years. We are clear that overall service levels, including new product development, are paramount to the success of this new business and believe similar opportunities exist with other potential customers. In the strategy update presented last year, we stated that we have set ourselves a long-term target to achieve a return on shareholders equity of 12% by 30 June 2006, and 15% by 30 June 2009. Excluding exceptional costs, return on equity for the 12 months to 8 January 2005 was 10%. Outlook The economic background is not expected to improve over the coming 6 months. Indeed, following the recently published December 2004 retail sales figures, our expectation and planning is that consumer spending could yet deteriorate further. This background and continuing price pressures are likely to make the second half of the financial year slightly tougher than originally anticipated. However, raw material and production savings from our Chinese operation, and sales from the new business referred to above, will start to come through towards the end of the fourth quarter and should have a positive impact going forward. The key to our future success remains our ability to innovate and create products that consumers wish to buy, at the same time we will not let-up on our relentless pursuit of improving our cost base and increasing operating efficiencies. Dividend The Board has maintained the dividend policy explained in the last annual report and accounts. This policy recognises the need, in the short term, for us to rebuild the level of dividend cover and increase the strength of the Group's balance sheet. In the medium term, our aim of pursuing a progressive dividend policy remains. Accordingly, the Board has declared an interim dividend of 2.8p per share, which is unchanged from that declared at the same time last year. The dividend will be paid on the 26 May 2005 to shareholders on the register on 13 May 2005, and the shares will go ex-dividend on 11 May 2005. J S Espey, Chairman 24 February 2005 Group Profit and Loss Account for the 28 weeks ended 8 January 2005 28 weeks 28 weeks 12 months ended ended ended 8 Jan 2005 10 Jan 2004 30 June 2004 (unaudited) (unaudited) Notes £'000 £'000 £'000 Turnover 1 24,677 23,433 48,763 Operating profit 1 860 588 1,584 Interest payable (240) (218) (419) Profit on ordinary activities before taxation 620 370 1,165 Tax on profit on ordinary activities (189) (107) (349) Profit attributable to shareholders 431 263 816 Dividends (316) (316) (541) Retained profit/(loss) 115 (53) 275 Dividend per ordinary share 3 2.8p 2.8p 4.8p Earnings per ordinary share - Basic 4 3.8p 2.3p 7.2p - Diluted 4 3.8p 2.3p 7.2p Group Balance Sheet as at 8 January 2005 As at As at As at 8 Jan 2005 10 Jan 2004 30 June 2004 (unaudited) (unaudited) £'000 £'000 £'000 Tangible fixed assets 12,501 12,682 12,382 Stocks 7,705 7,570 7,982 Debtors 7,130 5,632 14,219 Cash at bank and in hand 69 483 94 14,904 13,685 22,295 Creditors: amounts falling due within one year (9,765) (8,474) (14,998) Net current assets 5,139 5,211 7,297 Creditors: amounts falling due after more than one (4,514) (5,313) (6,668) year Provisions for liabilities and charges (947) (844) (947) 12,179 11,736 12,064 Share capital 563 563 563 Share premium 3,796 3,796 3,796 Reserves 7,820 7,377 7,705 Equity shareholders' funds 12,179 11,736 12,064 Group Statement of Cash Flows for the 28 weeks ended 8 January 2005 28 weeks 28 weeks 12 months ended ended ended 8 Jan 2005 10 Jan 2004 30 June 2004 (unaudited) (unaudited) £'000 £'000 £'000 Net cash inflow from operating activities (note I) 5,101 4,512 1,897 Returns on investments and servicing of finance (240) (218) (419) Corporation tax paid (162) (92) (190) Capital expenditure: Purchase of tangible fixed assets (860) (368) (696) Sale of tangible fixed assets 5 40 2 Equity dividends paid (225) (225) (541) Net cash inflow before financing 3,619 3,649 53 Financing: (Decrease) in long and short-term loans (2,003) (1,532) (32) Capital element of finance lease rentals (181) (200) (351) (2,184) (1,732) (383) Increase/(decrease) in cash 1,435 1,917 (330) Notes to the Statement of Cash Flows 28 weeks 28 weeks 12 months ended ended ended 8 Jan 2005 10 Jan 2004 30 June 2004 (unaudited) (unaudited) £'000 £'000 £'000 I. Reconciliation of operating profit to net cash inflow from operating activities Operating profit 860 588 1,584 Depreciation 741 822 1,488 (Profit) on disposal of fixed assets (5) (2) (2) Decrease/(increase) in stocks 277 46 (366) Decrease/(increase) in debtors 7,089 3,638 (4,952) (Decrease)/increase in creditors (3,861) (580) 4,145 Net cash inflow from operating activities 5,101 4,512 1,897 II. Analysis of net debt Net cash at bank and in hand 69 483 94 Overdraft (398) - (1,858) Short-term loans - (3) (3) Long-term loans (4,000) (4,500) (6,000) Finance leases (833) (1,165) (1,014) (5,162) (5,185) (8,781) III. Reconciliation of net cash flow to movement in net debt Net debt at start of the period (8,781) (8,834) (8,834) Increase/(decrease) in cash 1,435 1,917 (330) Decrease in borrowings and finance leases 2,184 1,732 383 Net debt at end of the period (5,162) (5,185) (8,781) Notes to the Financial Information 1. Turnover and segmental analysis 28 weeks ended 28 weeks ended 12 months ended 8 Jan 2005 10 Jan 2004 30 June 2004 Class of business Operating Operating Operating Profit Profit Profit Turnover Turnover Turnover £'000 £'000 £'000 £'000 £'000 £'000 (unaudited) (unaudited) (unaudited) (unaudited) Aerosol products 18,018 762 17,158 845 36,520 1,986 Cosmetic products 6,659 98 6,275 (257) 12,243 (6) 24,677 860 23,433 588 48,763 1,980 Operating profit before exceptional costs Exceptional costs - - - - - (396) Operating profit 24,677 860 23,433 588 48,763 1,584 2. The results for the twenty-eight weeks ended 8 January 2005 and the summary balance sheet on that date are unaudited. The results for the 12 month period ended 30 June 2004 do not constitute full accounts within the meaning of section 240 of the Companies Act 1985. Full accounts for that period together with an unqualified audit report thereon have been filed with the Registrar of Companies. 3. The dividend comprises an ordinary dividend of 2.8p (2004: 2.8p) per ordinary share payable on 26 May 2005 to shareholders on the register on 13 May 2005. 4. The calculation of basic earnings per share is based on 11,256,416 (2004: 11,256,416) ordinary shares of 5.0p each, being the weighted average number of ordinary shares in issue during the period, and the profit on ordinary activities after taxation of £431,000 (2004: £263,000). The diluted earnings per share is based on the profit for the period of £431,000 (2004: £263,000) and on the weighted average number of shares in issue for the period, adjusted for shares held under unexercised options. The adjusted number of shares for the period was 11,268,118 (2004: 11,266,316) ordinary shares which include 11,702 (2004: 9,900) dilutive potential ordinary shares from executive share options. 5. The Interim Report will be sent to shareholders and is available to members of the public at the Company's Registered Office at Swallowfield House, Station Road, Wellington, Somerset, TA21 8NL. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings